<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
     xmlns:media="http://search.yahoo.com/mrss/"
     xmlns:content="http://purl.org/rss/1.0/modules/content/"
     xmlns:wfw="http://wellformedweb.org/CommentAPI/"
     xmlns:dc="http://purl.org/dc/elements/1.1/"
     xmlns:atom="http://www.w3.org/2005/Atom"
     xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
     xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
    xmlns:company="http:/purl.org/rss/1.0/modules/company" xmlns:fool="https://fool.com/rss/extensions"     >

    <channel>
        <title>Cokal Limited (ASX:CKA) Share Price News | The Motley Fool Australia</title>
        <atom:link href="https://www.fool.com.au/tickers/asx-cka/feed/" rel="self" type="application/rss+xml" />
        <link>https://www.fool.com.au/tickers/asx-cka/</link>
        <description>Since 1993, millions of investors have trusted The Motley Fool for simple, down-to-earth investing research.</description>
        <lastBuildDate>Sun, 19 Apr 2026 20:15:13 +0000</lastBuildDate>
        <language>en-AU</language>
                <sy:updatePeriod>hourly</sy:updatePeriod>
                <sy:updateFrequency>1</sy:updateFrequency>
        <generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://www.fool.com.au/wp-content/uploads/2020/06/cropped-cap-icon-freesite-96x96.png</url>
	<title>Cokal Limited (ASX:CKA) Share Price News | The Motley Fool Australia</title>
	<link>https://www.fool.com.au/tickers/asx-cka/</link>
	<width>32</width>
	<height>32</height>
</image> 
<atom:link rel="hub" href="https://pubsubhubbub.appspot.com"/>
<atom:link rel="hub" href="https://pubsubhubbub.superfeedr.com"/>
<atom:link rel="hub" href="https://websubhub.com/hub"/>
<atom:link rel="self" href="https://www.fool.com.au/tickers/asx-cka/feed/"/>
            <item>
                                <title>10 stocks up by more than 50% in the past month</title>
                <link>https://www.fool.com.au/2015/03/11/10-stocks-up-by-more-than-50-in-the-past-month/</link>
                                <pubDate>Wed, 11 Mar 2015 04:18:36 +0000</pubDate>
                <dc:creator><![CDATA[Mike King]]></dc:creator>
                		<category><![CDATA[⏸️ Investing]]></category>

                <guid isPermaLink="false">https://fool.com.au/?p=85216</guid>
                                    <description><![CDATA[<p>The market has gone nowhere in the past month, but these 10 stocks are up by more than 50%</p>
<p>The post <a href="https://www.fool.com.au/2015/03/11/10-stocks-up-by-more-than-50-in-the-past-month/">10 stocks up by more than 50% in the past month</a> appeared first on <a href="https://www.fool.com.au">The Motley Fool Australia</a>.</p>
]]></description>
                                                                                            <content:encoded><![CDATA[<p>Over the past month, the ASX has gone virtually nowhere, with the <strong>All Ordinaries</strong> (INDEXASX: XAO) (ASX: XAO) down 0.4% and the <strong>S&amp;P/ASX 200</strong> (INDEXASX: XJO) (ASX: XJO) up 0.5%.</p>
<p>But that doesn't mean all stocks listed on the Australian Stock Exchange have gone nowhere. In fact, 10 companies have seen their share prices soar by more than 50%, and 4 of these have more than <strong><em>doubled</em></strong>.</p>
<p><strong>Cynata Therapeutics Ltd&nbsp;</strong>(<a class="tickerized-link" href="https://www.fool.com.au/tickers/asx-cyp/">ASX: CYP</a>) has leapt 228% since early February to $1.18. The stem cell research company achieved a major breakthrough, achieving commercial-scale manufacture of stem cell products. As you can well imagine, that has major implications if Cynata can go on and commercialise its technology.</p>
<p><strong>AtCor Medical Holdings Limited</strong> (ASX: ACG) is up 120% to 21 cents. AtCor received Category 1 approval for its SphygmoCor blood pressure system in the US. Colleague Brendon Lau covered the news in more detail <a href="https://www.fool.com.au/2015/03/10/is-this-company-the-next-nanosonics-ltd-or-impedimed-limited/" target="_blank" rel="noopener">here</a>.</p>
<p><strong>Cyclopharm Limited</strong> (<a class="tickerized-link" href="https://www.fool.com.au/tickers/asx-cyc/">ASX: CYC</a>) jumped 116.9% to 64 cents, after reporting record sales of $12 million and an record net profit of $4m – although that included a $2.65 million legal settlement. Cyclopharm is a nuclear medicine company, with products including Technegas for lung imaging. Has the company turned the corner like CEO James McBrayer thinks it has?</p>
<p><strong>Cokal Ltd</strong> (<a class="tickerized-link" href="https://www.fool.com.au/tickers/asx-cka/">ASX: CKA</a>) has seen its shares soar 128.6% to 10 cents, despite the company being a coal explorer. In late February, Cokal received construction and operational approval for its Bumi Barito Mineral (BBM) Project port facilities in Indonesia. BBM is expected to produce a premium coking coal over a period of more than 15 years.</p>
<p><strong>TNG Limited</strong> (ASX: TNG) has gained 77.8% to trade around 17 cents currently. TNG is focused on developing its flagship Mount Peak Vanadium-Titanium-Iron project near Alice Springs, which the company says can deliver revenues of $13.6 billion. Yesterday TNG signed an offtake agreement with Korean metals group WOOJIN IND. Co. for up to 60% of forecast production.</p>
<p><strong>Aeris Environmental Ltd</strong> (<a class="tickerized-link" href="https://www.fool.com.au/tickers/asx-aei/">ASX: AEI</a>) shares have climbed 50.7% to trade around 51 cents currently. Aeris is an expert in the removal of bacteria and mould that naturally builds up in air-conditioning, cold storage and bulk water systems and then protects the asset from further recontamination. Aeris recently reported strong growth in purchase orders and potential pipeline of large scale projects.</p>
<p><strong>1-Page Limited</strong> (ASX: 1PG) has jumped 66.7% to $1.65 after the company signed a number of major deals, including giant US retailer Amazon for its 1-Page sourcing and referral engine. 1-Page offers companies a new way to hire prospective employees.</p>
<p><strong>Joyce Corporation Ltd</strong> (<a class="tickerized-link" href="https://www.fool.com.au/tickers/asx-jyc/">ASX: JYC</a>) has gained 50.8% to trade at 95 cents. The company owns a chain of bedding stores under the BedShed brand. Joyce recently sold a property for $25 million, and the board is considering a suitable return to shareholders of the settlement proceeds, expected to be a franked special dividend of 5 cents per share each year for the next three years. Joyce is forecast to pay 10.5 cents in total this year.</p>
<p><strong>Anatarra Lifesciences Ltd</strong> (<a class="tickerized-link" href="https://www.fool.com.au/tickers/asx-anr/">ASX: ANR</a>) is up 57.6% to 52 cents. Anatarra develops non-antibiotic solutions for gastrointestinal diseases in animals and humans, and recently reported a successful trial on a pig farm of its Detach product. Anatarra is now focused on registering Detach in Europe and the USA, and hopes to launch Detach in 2016 in Australia.</p>
<p>Last but not least is <strong>Digital CC Ltd</strong> (<a class="tickerized-link" href="https://www.fool.com.au/tickers/asx-dcc/">ASX: DCC</a>) which is up 66.7% to 14 cents. The company is a digital payments company – the first bitcoin focused company listed on a major exchange. Bitcoin is a digital currency that is usually in the news for the wrong reasons, and there's no guarantee that Bitcoin will be successful.</p>
<p>The post <a href="https://www.fool.com.au/2015/03/11/10-stocks-up-by-more-than-50-in-the-past-month/">10 stocks up by more than 50% in the past month</a> appeared first on <a href="https://www.fool.com.au">The Motley Fool Australia</a>.</p>
]]></content:encoded>
                                                                                                                    </item>
                    </channel>
</rss>
